| Year |
Citation |
Score |
| 2023 |
Tufekcioglu Z, Lange J, Pedersen KF, Tysnes OB, Alves G, Emre M. Cognitive Profile in Parkinson's Disease Dementia Patients with Low versus Normal Cerebrospinal Fluid Amyloid Beta. Dementia and Geriatric Cognitive Disorders Extra. 13: 39-47. PMID 38025590 DOI: 10.1159/000534552 |
0.321 |
|
| 2022 |
Sumbul-Sekerci B, Bilgic B, Pasin O, Emre M, Hanagasi HA. Anticholinergic Burden, Polypharmacy, and Cognition in Parkinson's Disease Patients with Mild Cognitive Impairment: A Cross-Sectional Observational Study. Dementia and Geriatric Cognitive Disorders. 1-10. PMID 36273437 DOI: 10.1159/000526863 |
0.312 |
|
| 2022 |
Sumbul-Sekerci B, Hanagasi HA, Bilgic B, Tufekcioglu Z, Gurvit H, Emre M. Medication management and treatment adherence in Parkinson's disease patients with mild cognitive impairment. Acta Neurologica Belgica. PMID 35325434 DOI: 10.1007/s13760-022-01916-1 |
0.31 |
|
| 2021 |
Samanci B, Bilgiç B, Gelişin Ö, Tepgeç F, Guven G, Tüfekçioğlu Z, Alaylıoğlu M, Hanagasi HA, Gürvit H, Guerreiro R, Hardy J, Emre M. TREM2 variants as a possible cause of frontotemporal dementia with distinct neuroimaging features. European Journal of Neurology. PMID 33969597 DOI: 10.1111/ene.14908 |
0.303 |
|
| 2020 |
Lesage S, Lunati A, Houot M, Romdhan SB, Clot F, Tesson C, Mangone G, Toullec BL, Courtin T, Larcher K, Benmahdjoub M, Arezki M, Bouhouche A, Anheim M, Roze E, ... ... Emre M, et al. Characterization of recessive Parkinson's disease in a large multicenter study. Annals of Neurology. PMID 32472966 DOI: 10.1002/Ana.25787 |
0.345 |
|
| 2020 |
Yunisova G, Tufekcioglu Z, Dogu O, Bilgic B, Kaleagasi H, Akca Kalem S, Lohmann E, Gurvit HI, Emre M, Hanagasi HA. Patients with Lately Diagnosed Cerebrotendinous Xanthomatosis. Neuro-Degenerative Diseases. 1-7. PMID 32349000 DOI: 10.1159/000506770 |
0.315 |
|
| 2019 |
Sezgin M, Bilgic B, Tinaz S, Emre M. Parkinson's Disease Dementia and Lewy Body Disease. Seminars in Neurology. 39: 274-282. PMID 30925619 DOI: 10.1055/S-0039-1678579 |
0.435 |
|
| 2018 |
Akbostanci MC, Bayram E, Yilmaz V, Rzayev S, Özkan S, Tokcaer AB, Saka E, Durmaz Celik FN, Barut BÖ, Tüfekcioglu Z, Acarer A, Balaban H, Erer S, Dogu O, Kibaroglu S, ... ... Emre M, et al. Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating Scale. Movement Disorders Clinical Practice. 5: 54-59. PMID 30363359 DOI: 10.1002/Mdc3.12556 |
0.303 |
|
| 2018 |
Dursun E, Alaylıoğlu M, Atasoy IL, Sengul B, Buyukiscan ES, Yildirim E, Sezgin M, Samanci B, Tufekcioglu Z, Tatlidede AD, Bilgiç B, Hanagasi HA, Emre M, Gurvit HI, Gezen-Ak D. P2-244: The Correlation Between Csf Amyloid Beta 1-42 Levels And Csf Vitamin D (25Ohd) Levels In Patients With Sporadic Alzheimer'S Disease Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.931 |
0.314 |
|
| 2017 |
Uysal-Cantürk P, Hanağasi HA, Bilgiç B, Gürvit H, Emre M. An assessment of Movement Disorder Society Task Force Diagnostic Criteria for Mild Cognitive Impairment in Parkinson's Disease. European Journal of Neurology. PMID 28941002 DOI: 10.1111/Ene.13467 |
0.422 |
|
| 2017 |
Hanagasi HA, Tufekcioglu Z, Emre M. Dementia in Parkinson's disease. Journal of the Neurological Sciences. PMID 28088312 DOI: 10.1016/J.Jns.2017.01.012 |
0.451 |
|
| 2016 |
Senturk G, Bilgic B, Arslan AB, Bayram A, Hanagasi H, Gurvit H, Emre M. Cognitive and anatomical correlates of anosognosia in amnestic mild cognitive impairment and early-stage Alzheimer's disease. International Psychogeriatrics. 1-10. PMID 27780496 DOI: 10.1017/S1041610216001812 |
0.39 |
|
| 2016 |
Guven G, Lohmann E, Bras J, Gibbs JR, Gurvit H, Bilgic B, Hanagasi H, Rizzu P, Heutink P, Emre M, Erginel-Unaltuna N, Just W, Hardy J, Singleton A, Guerreiro R. Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients. Plos One. 11: e0162592. PMID 27632209 DOI: 10.1371/Journal.Pone.0162592 |
0.332 |
|
| 2016 |
Hanagasi HA, Giri A, Guven G, Bilgiç B, Hauser AK, Emre M, Heutink P, Basak N, Gasser T, Simón-Sánchez J, Lohmann E. A novel homozygous DJ1 mutation causes parkinsonism and ALS in a Turkish family. Parkinsonism & Related Disorders. PMID 26972524 DOI: 10.1016/J.Parkreldis.2016.03.001 |
0.302 |
|
| 2016 |
Tufekcioglu Z, Cakar A, Bilgic B, Hanagasi H, Gurvit H, Emre M. Adult-onset phenylketonuria with rapidly progressive dementia and parkinsonism. Neurocase. 1-3. PMID 26962957 DOI: 10.1080/13554794.2016.1142567 |
0.378 |
|
| 2016 |
Lesage S, Drouet V, Majounie E, Deramecourt V, Jacoupy M, Nicolas A, Cormier-Dequaire F, Hassoun SM, Pujol C, Ciura S, Erpapazoglou Z, Usenko T, Maurage CA, Sahbatou M, Liebau S, ... ... Emre M, et al. Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent Mitophagy. American Journal of Human Genetics. 98: 500-13. PMID 26942284 DOI: 10.1016/J.Ajhg.2016.01.014 |
0.348 |
|
| 2014 |
Emre M, Ford PJ, Bilgiç B, Uç EY. Cognitive impairment and dementia in Parkinson's disease: practical issues and management. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 663-72. PMID 24757114 DOI: 10.1002/Mds.25870 |
0.437 |
|
| 2014 |
Emre M, Poewe W, De Deyn PP, Barone P, Kulisevsky J, Pourcher E, van Laar T, Storch A, Micheli F, Burn D, Durif F, Pahwa R, Callegari F, Tenenbaum N, Strohmaier C. Long-term safety of rivastigmine in parkinson disease dementia: an open-label, randomized study. Clinical Neuropharmacology. 37: 9-16. PMID 24434526 DOI: 10.1097/Wnf.0000000000000010 |
0.402 |
|
| 2014 |
Hanagasi HA, Uysal-Cantürk P, Bilgic B, Gurvit H, Emre M. P1-343: MOCA, MMSE, AND ACE-R FOR THE ASSESSMENT OF MILD COGNITIVE IMPAIRMENT IN PATIENTS WITH PARKINSON's DISEASE Alzheimer's & Dementia. 10: P438-P438. DOI: 10.1016/J.Jalz.2014.05.584 |
0.403 |
|
| 2014 |
Bilgic B, Gelisin O, Guerreiro R, Lohmann E, Hanagasi HA, Gurvit H, Emre M. P1-287: NEUROIMAGING FINDINGS OF NASU-HAKOLA DISEASE Alzheimer's & Dementia. 10: P415-P415. DOI: 10.1016/J.Jalz.2014.05.527 |
0.315 |
|
| 2013 |
Hanagasi HA, Bilgiç B, Emre M. Neuroimaging, biomarkers, and management of dementia with lewy bodies. Frontiers in Neurology. 4: 151. PMID 24109473 DOI: 10.3389/Fneur.2013.00151 |
0.382 |
|
| 2013 |
Guerreiro R, Bilgic B, Guven G, Brás J, Rohrer J, Lohmann E, Hanagasi H, Gurvit H, Emre M. Novel compound heterozygous mutation in TREM2 found in a Turkish frontotemporal dementia-like family. Neurobiology of Aging. 34: 2890.e1-5. PMID 23870839 DOI: 10.1016/J.Neurobiolaging.2013.06.005 |
0.301 |
|
| 2013 |
Rana AQ, Khondker S, Kabir A, Owalia A, Khondker S, Emre M. Impact of cognitive dysfunction on drooling in Parkinson's disease. European Neurology. 70: 42-5. PMID 23711510 DOI: 10.1159/000348571 |
0.321 |
|
| 2013 |
Guerreiro RJ, Lohmann E, Brás JM, Gibbs JR, Rohrer JD, Gurunlian N, Dursun B, Bilgic B, Hanagasi H, Gurvit H, Emre M, Singleton A, Hardy J. Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. Jama Neurology. 70: 78-84. PMID 23318515 DOI: 10.1001/Jamaneurol.2013.579 |
0.365 |
|
| 2013 |
Araz OS, Dursun E, Gezen-Ak D, Hanagasi H, Bilgiç B, Lohmann E, Ertan T, Gurvit H, Eker E, Emre M, Yilmazer S. Association between vitamin D binding protein (VDBP) haplotype and late-onset Alzheimer's disease Alzheimers & Dementia. 9: 177. DOI: 10.1016/J.Jalz.2013.05.289 |
0.307 |
|
| 2013 |
Topcular B, Ozerden M, Behrem N, Altinkaya A, Sakalli NK, Kirbas D, Hanagasi H, Emre M. P4-131: Cognitive impairment in neurosyphilis: Alzheimer's disease-like pattern? Alzheimer's & Dementia. 9: P752-P752. DOI: 10.1016/J.Jalz.2013.05.1521 |
0.41 |
|
| 2013 |
Topcular B, Behrem N, Ozerden M, Altinkaya A, Sakalli NK, Kirbas D, Hanagasi H, Emre M. P4-090: Frequency and causes of early-onset dementia in a tertiary referral center in Istanbul Alzheimer's & Dementia. 9: P737-P737. DOI: 10.1016/J.Jalz.2013.05.1479 |
0.318 |
|
| 2013 |
Senturk G, Bilgic B, Kenar C, Hanagasi H, Gurvit H, Emre M. P3-110: Neuropsychological evaluation and cortical thickness analysis of anasognosia in mild cognitive impairment and Alzheimer's disease Alzheimer's & Dementia. 9: P592-P592. DOI: 10.1016/J.Jalz.2013.05.1181 |
0.409 |
|
| 2013 |
Bilgic B, Senturk G, Hanagasi H, Gurvit H, Emre M. P3-096: Neural correlates of lack of insight in mild cognitive impairment and Alzheimer's disease Alzheimer's & Dementia. 9: P587-P587. DOI: 10.1016/J.Jalz.2013.05.1166 |
0.356 |
|
| 2012 |
Gezen-Ak D, Dursun E, Bilgiç B, Hanağasi H, Ertan T, Gürvit H, Emre M, Eker E, Ulutin T, Uysal O, Yilmazer S. Vitamin D receptor gene haplotype is associated with late-onset Alzheimer's disease. The Tohoku Journal of Experimental Medicine. 228: 189-96. PMID 23076256 DOI: 10.1620/Tjem.228.189 |
0.303 |
|
| 2012 |
Dubois B, Tolosa E, Katzenschlager R, Emre M, Lees AJ, Schumann G, Pourcher E, Gray J, Thomas G, Swartz J, Hsu T, Moline ML. Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1230-8. PMID 22915447 DOI: 10.1002/Mds.25098 |
0.395 |
|
| 2012 |
Lohmann E, Guerreiro RJ, Erginel-Unaltuna N, Gurunlian N, Bilgic B, Gurvit H, Hanagasi HA, Luu N, Emre M, Singleton A. Identification of PSEN1 and PSEN2 gene mutations and variants in Turkish dementia patients. Neurobiology of Aging. 33: 1850.e17-27. PMID 22503161 DOI: 10.1016/J.Neurobiolaging.2012.02.020 |
0.382 |
|
| 2012 |
Bilgic B, Bayram A, Arslan AB, Hanagasi H, Dursun B, Gurvit H, Emre M, Lohmann E. Differentiating symptomatic Parkin mutations carriers from patients with idiopathic Parkinson's disease: contribution of automated segmentation neuroimaging method. Parkinsonism & Related Disorders. 18: 562-6. PMID 22445249 DOI: 10.1016/J.Parkreldis.2012.02.017 |
0.378 |
|
| 2012 |
Reichmann H, Emre M. Optimizing levodopa therapy to treat wearing-off symptoms in Parkinson's disease: focus on levodopa/carbidopa/entacapone. Expert Review of Neurotherapeutics. 12: 119-31. PMID 22288667 DOI: 10.1586/Ern.11.203 |
0.339 |
|
| 2012 |
Litvan I, Goldman JG, Tröster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, ... Emre M, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 349-56. PMID 22275317 DOI: 10.1002/Mds.24893 |
0.411 |
|
| 2012 |
Lohmann E, Dursun B, Lesage S, Hanagasi HA, Sevinc G, Honore A, Bilgic B, Gürvit H, Dogu O, Kaleagası H, Babacan G, Yazici J, Erginel-Unaltuna N, Brice A, Emre M. Genetic bases and phenotypes of autosomal recessive Parkinson disease in a Turkish population. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 19: 769-75. PMID 22233331 DOI: 10.1111/J.1468-1331.2011.03639.X |
0.317 |
|
| 2012 |
Rascol O, Barone P, Behari M, Emre M, Giladi N, Olanow CW, Ruzicka E, Bibbiani F, Squillacote D, Patten A, Tolosa E. Perampanel in Parkinson disease fluctuations: a double-blind randomized trial with placebo and entacapone. Clinical Neuropharmacology. 35: 15-20. PMID 22222634 DOI: 10.1097/Wnf.0B013E318241520B |
0.369 |
|
| 2012 |
Guerreiro RJ, Lohmann E, Kinsella E, Brás JM, Luu N, Gurunlian N, Dursun B, Bilgic B, Santana I, Hanagasi H, Gurvit H, Gibbs JR, Oliveira C, Emre M, Singleton A. Exome sequencing reveals an unexpected genetic cause of disease: NOTCH3 mutation in a Turkish family with Alzheimer's disease. Neurobiology of Aging. 33: 1008.e17-23. PMID 22153900 DOI: 10.1016/J.Neurobiolaging.2011.10.009 |
0.354 |
|
| 2012 |
Lohmann E, Hanağası HA, Gürvit H, Kayacı G, Ruberg M, Yazıcı J, Emre M. The impact of familial structure on Parkinson's disease in Istanbul Medical School, Turkey. The International Journal of Neuroscience. 122: 102-5. PMID 21995451 DOI: 10.3109/00207454.2011.631715 |
0.344 |
|
| 2011 |
Barone P, Aarsland D, Burn D, Emre M, Kulisevsky J, Weintraub D. Cognitive impairment in nondemented Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2483-95. PMID 22170275 DOI: 10.1002/Mds.23919 |
0.421 |
|
| 2011 |
Hanagasi HA, Gurvit H, Unsalan P, Horozoglu H, Tuncer N, Feyzioglu A, Gunal DI, Yener GG, Cakmur R, Sahin HA, Emre M. The effects of rasagiline on cognitive deficits in Parkinson's disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1851-8. PMID 21500280 DOI: 10.1002/Mds.23738 |
0.448 |
|
| 2011 |
Poletti M, Emre M, Bonuccelli U. Mild cognitive impairment and cognitive reserve in Parkinson's disease. Parkinsonism & Related Disorders. 17: 579-86. PMID 21489852 DOI: 10.1016/J.Parkreldis.2011.03.013 |
0.42 |
|
| 2011 |
Bronnick K, Emre M, Tekin S, Haugen SB, Aarsland D. Cognitive correlates of visual hallucinations in dementia associated with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 824-9. PMID 21437985 DOI: 10.1002/Mds.23525 |
0.435 |
|
| 2011 |
Hanagasi HA, Akat S, Gurvit H, Yazici J, Emre M. Pain is common in Parkinson's disease. Clinical Neurology and Neurosurgery. 113: 11-3. PMID 20800342 DOI: 10.1016/J.Clineuro.2010.07.024 |
0.305 |
|
| 2011 |
Bilgic B, Bayram A, Alpsan H, Tumac A, Hanagasi H, Sahin H, Lohmann E, Emre M, Gurvit H. P4-086: Frontal white matter hyperintensities correlate with depressive symptoms and functionality in mild Alzheimer's patients Alzheimer's & Dementia. 7: S731-S731. DOI: 10.1016/J.Jalz.2011.05.2107 |
0.334 |
|
| 2010 |
Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, Burn D, Barone P, Pagonabarraga J, Allcock L, Santangelo G, Foltynie T, Janvin C, Larsen JP, Barker RA, ... Emre M, et al. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology. 75: 1062-9. PMID 20855849 DOI: 10.1212/Wnl.0B013E3181F39D0E |
0.331 |
|
| 2010 |
Emre M, Tsolaki M, Bonuccelli U, Destée A, Tolosa E, Kutzelnigg A, Ceballos-Baumann A, Zdravkovic S, Bladström A, Jones R. Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial. The Lancet. Neurology. 9: 969-77. PMID 20729148 DOI: 10.1016/S1474-4422(10)70194-0 |
0.413 |
|
| 2010 |
Paisán-Ruiz C, Guevara R, Federoff M, Hanagasi H, Sina F, Elahi E, Schneider SA, Schwingenschuh P, Bajaj N, Emre M, Singleton AB, Hardy J, Bhatia KP, Brandner S, Lees AJ, et al. Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1791-800. PMID 20669327 DOI: 10.1002/Mds.23221 |
0.363 |
|
| 2010 |
Lindesay J, Bullock R, Daniels H, Emre M, Förstl H, Frölich L, Gabryelewicz T, MartÃnez-Lage P, Monsch AU, Tsolaki M, van Laar T. Turning principles into practice in Alzheimer's disease. International Journal of Clinical Practice. 64: 1198-209. PMID 20529136 DOI: 10.1111/J.1742-1241.2010.02417.X |
0.386 |
|
| 2010 |
Eggert K, Squillacote D, Barone P, Dodel R, Katzenschlager R, Emre M, Lees AJ, Rascol O, Poewe W, Tolosa E, Trenkwalder C, Onofrj M, Stocchi F, Nappi G, Kostic V, et al. Safety and efficacy of perampanel in advanced Parkinson's disease: a randomized, placebo-controlled study. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 896-905. PMID 20461807 DOI: 10.1002/Mds.22974 |
0.352 |
|
| 2010 |
Emre M, Bernabei R, Blesa R, Bullock R, Cunha L, Daniëls H, Dziadulewicz E, Förstl H, Frölich L, Gabryelewicz T, Levin O, Lindesay J, MartÃnez-Lage P, Monsch A, Tsolaki M, et al. Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease. Cns Neuroscience & Therapeutics. 16: 246-53. PMID 20370805 DOI: 10.1111/J.1755-5949.2010.00141.X |
0.35 |
|
| 2010 |
Cummings J, Emre M, Aarsland D, Tekin S, Dronamraju N, Lane R. Effects of rivastigmine in Alzheimer's disease patients with and without hallucinations. Journal of Alzheimer's Disease : Jad. 20: 301-11. PMID 20164585 DOI: 10.3233/Jad-2010-1362 |
0.447 |
|
| 2010 |
Gurvit HI, Baral-Kulaksizoglu I, Emre M, Babacan G, Hanagasi H. An observational study in naturalistic setting on the efficacy of memantine on behavioral symptoms of Alzheimer's disease Alzheimer's & Dementia. 6: S310. DOI: 10.1016/J.Jalz.2010.05.1012 |
0.352 |
|
| 2009 |
Emre M. Memantine: a new hope for treatment of Lewy body-related dementias? The Lancet. Neurology. 8: 594-5. PMID 19520612 DOI: 10.1016/S1474-4422(09)70144-9 |
0.316 |
|
| 2009 |
Dursun E, Gezen-Ak D, Ertan T, Bilgiç B, Gürvit H, Emre M, Eker E, Engin F, Uysal O, Yilmazer S. Interleukin-1alpha -889 C/T polymorphism in Turkish patients with late-onset Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 27: 82-7. PMID 19155622 DOI: 10.1159/000193627 |
0.362 |
|
| 2009 |
Verbaan D, van Rooden SM, Visser M, Marinus J, Emre M, van Hilten JJ. Psychotic and compulsive symptoms in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 738-44. PMID 19133665 DOI: 10.1002/Mds.22453 |
0.4 |
|
| 2009 |
Lane R, He Y, Morris C, Leverenz JB, Emre M, Ballard C. BuChE-K and APOE epsilon4 allele frequencies in Lewy body dementias, and influence of genotype and hyperhomocysteinemia on cognitive decline. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 392-400. PMID 19006190 DOI: 10.1002/Mds.22357 |
0.398 |
|
| 2008 |
Goetz CG, Emre M, Dubois B. Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis. Annals of Neurology. 64: S81-92. PMID 19127578 DOI: 10.1002/Ana.21455 |
0.397 |
|
| 2008 |
Dursun E, Gezen-Ak D, Eker E, Ertan T, Engin F, Hanagasi H, Gürvit H, Emre M, Yilmazer S. Presenilin-1 gene intronic polymorphism and late-onset Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology. 21: 268-73. PMID 19017784 DOI: 10.1177/0891988708324941 |
0.402 |
|
| 2008 |
Parildar-Karpuzoğlu H, Doğru-Abbasoğlu S, Hanagasi HA, Karadağ B, Gürvit H, Emre M, Uysal M. Single nucleotide polymorphisms in base-excision repair genes hOGG1, APE1 and XRCC1 do not alter risk of Alzheimer's disease. Neuroscience Letters. 442: 287-91. PMID 18672023 DOI: 10.1016/J.Neulet.2008.07.047 |
0.328 |
|
| 2008 |
Emre M, Mecocci P, Stender K. Pooled analyses on cognitive effects of memantine in patients with moderate to severe Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 14: 193-9. PMID 18560130 DOI: 10.3233/Jad-2008-14207 |
0.442 |
|
| 2008 |
Gurvit H, Emre M, Tinaz S, Bilgic B, Hanagasi H, Sahin H, Gurol E, Kvaloy JT, Harmanci H. The prevalence of dementia in an urban Turkish population. American Journal of Alzheimer's Disease and Other Dementias. 23: 67-76. PMID 18276959 DOI: 10.1177/1533317507310570 |
0.36 |
|
| 2008 |
Oertel W, Poewe W, Wolters E, De Deyn PP, Emre M, Kirsch C, Hsu C, Tekin S, Lane R. Effects of rivastigmine on tremor and other motor symptoms in patients with Parkinson's disease dementia: a retrospective analysis of a double-blind trial and an open-label extension. Drug Safety. 31: 79-94. PMID 18095748 DOI: 10.2165/00002018-200831010-00007 |
0.419 |
|
| 2008 |
Hanagasi HA, Parildar-Karpuzoglu H, Dogru-Abbasoglu S, Karadag B, Gurvit H, Emre M, Uysal M. P3-227: Polymorphisms in the DNA repair genes, hOGG1 and APE1 and the risk of Alzheimer's disease Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1794 |
0.316 |
|
| 2007 |
Emre M. Clinical features, pathophysiology and treatment of dementia associated with Parkinson's disease. Handbook of Clinical Neurology. 83: 401-19. PMID 18808925 DOI: 10.1016/S0072-9752(07)83018-1 |
0.449 |
|
| 2007 |
Emre M. Treatment of dementia associated with Parkinson's disease. Parkinsonism & Related Disorders. 13: S457-61. PMID 18267283 DOI: 10.1016/S1353-8020(08)70049-X |
0.436 |
|
| 2007 |
Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, ... ... Emre M, et al. Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 2314-24. PMID 18098298 DOI: 10.1002/Mds.21844 |
0.339 |
|
| 2007 |
Emre M, Cummings JL, Lane RM. Rivastigmine in dementia associated with Parkinson's disease and Alzheimer's disease: similarities and differences. Journal of Alzheimer's Disease : Jad. 11: 509-19. PMID 17656830 DOI: 10.3233/Jad-2007-11412 |
0.455 |
|
| 2007 |
Gezen-Ak D, Dursun E, Ertan T, Hanağasi H, Gürvit H, Emre M, Eker E, Oztürk M, Engin F, Yilmazer S. Association between vitamin D receptor gene polymorphism and Alzheimer's disease. The Tohoku Journal of Experimental Medicine. 212: 275-82. PMID 17592215 DOI: 10.1620/Tjem.212.275 |
0.313 |
|
| 2007 |
Friedland RP, Emre M, Geula C. The 3rd International Symposium on Alzheimer's Disease and Related Disorders in the Middle East, Istanbul, Turkey, October 1 - 2, 2005. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 14: 161-8. PMID 17577692 DOI: 10.1080/13506120701259606 |
0.345 |
|
| 2007 |
Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 1689-707; quiz 1837. PMID 17542011 DOI: 10.1002/Mds.21507 |
0.372 |
|
| 2007 |
Ehrt U, Brønnick K, De Deyn PP, Emre M, Tekin S, Lane R, Aarsland D. Subthreshold depression in patients with Parkinson's disease and dementia--clinical and demographic correlates. International Journal of Geriatric Psychiatry. 22: 980-5. PMID 17393542 DOI: 10.1002/Gps.1774 |
0.355 |
|
| 2007 |
Doğru-Abbasoğlu S, Aykaç-Toker G, Hanagasi HA, Gürvit H, Emre M, Uysal M. The Arg194Trp polymorphism in DNA repair gene XRCC1 and the risk for sporadic late-onset Alzheimer's disease. Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology. 28: 31-4. PMID 17385092 DOI: 10.1007/S10072-007-0744-X |
0.306 |
|
| 2007 |
Lippa CF, Duda JE, Grossman M, Hurtig HI, Aarsland D, Boeve BF, Brooks DJ, Dickson DW, Dubois B, Emre M, Fahn S, Farmer JM, Galasko D, Galvin JE, Goetz CG, et al. DLB and PDD boundary issues: diagnosis, treatment, molecular pathology, and biomarkers. Neurology. 68: 812-9. PMID 17353469 DOI: 10.1212/01.Wnl.0000256715.13907.D3 |
0.388 |
|
| 2007 |
Gürses C, Kürtüncü M, Jirsch J, Yeşilot N, Hanağasi H, Bebek N, Baykan B, Emre M, Gökyiğit A, Andermann F. Neurosyphilis presenting with status epilepticus. Epileptic Disorders : International Epilepsy Journal With Videotape. 9: 51-6. PMID 17307712 DOI: 10.1684/Epd.2007.0058 |
0.307 |
|
| 2007 |
Bronnick K, Emre M, Lane R, Tekin S, Aarsland D. Profile of cognitive impairment in dementia associated with Parkinson's disease compared with Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 78: 1064-8. PMID 17287236 DOI: 10.1136/Jnnp.2006.108076 |
0.452 |
|
| 2007 |
Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, Scheltens P, Tariska P, Winblad B. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 14: e1-26. PMID 17222085 DOI: 10.1111/J.1468-1331.2006.01605.X |
0.4 |
|
| 2007 |
Aarsland D, Brønnick K, Ehrt U, De Deyn PP, Tekin S, Emre M, Cummings JL. Neuropsychiatric symptoms in patients with Parkinson's disease and dementia: frequency, profile and associated care giver stress. Journal of Neurology, Neurosurgery, and Psychiatry. 78: 36-42. PMID 16820421 DOI: 10.1136/Jnnp.2005.083113 |
0.356 |
|
| 2007 |
Emre M. 3.IS.2. The changing face of Parkinson's disease: From Motor symptoms to cognition to neuroprotection (Merck Serono International) Parkinsonism & Related Disorders. 13. DOI: 10.1016/S1353-8020(08)70939-8 |
0.368 |
|
| 2007 |
Hanagasi H, Coban A, Bilgic S, Gurvit H, Yazici J, Barlas O, Emre M. 3.240 Comparison of unilateral pallidotomy versus subthalamotomy in advanced idiopathic Parkinson's disease Parkinsonism & Related Disorders. 13: S172-S173. DOI: 10.1016/S1353-8020(08)70877-0 |
0.361 |
|
| 2006 |
Lippa CF, Emre M. Characterizing clinical phenotypes: the Lewys in their life or the life of their Lewys? Neurology. 67: 1910-1. PMID 17159092 DOI: 10.1212/01.Wnl.0000250234.72903.37 |
0.346 |
|
| 2006 |
Burn D, Emre M, McKeith I, De Deyn PP, Aarsland D, Hsu C, Lane R. Effects of rivastigmine in patients with and without visual hallucinations in dementia associated with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1899-907. PMID 16960863 DOI: 10.1002/Mds.21077 |
0.379 |
|
| 2006 |
Dogru-Abbasoglu S, Inceoglu M, Parildar-Karpuzoglu H, Hanagasi HA, Karadag B, Gurvit H, Emre M, Aykac-Toker G, Uysal M. Polymorphisms in the DNA repair genes XPD (ERCC2) and XPF (ERCC4) are not associated with sporadic late-onset Alzheimer's disease. Neuroscience Letters. 404: 258-61. PMID 16806697 DOI: 10.1016/J.Neulet.2006.06.005 |
0.323 |
|
| 2006 |
Alves G, Larsen JP, Emre M, Wentzel-Larsen T, Aarsland D. Changes in motor subtype and risk for incident dementia in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1123-30. PMID 16637023 DOI: 10.1002/Mds.20897 |
0.456 |
|
| 2006 |
Sahin HA, Emre M, Ziabreva I, Perry E, Celasun B, Perry R. The distribution pattern of pathology and cholinergic deficits in amygdaloid complex in Alzheimer's disease and dementia with Lewy bodies. Acta Neuropathologica. 111: 115-25. PMID 16468020 DOI: 10.1007/S00401-005-0003-2 |
0.346 |
|
| 2006 |
Sahin HA, Gurvit IH, Emre M, Hanagasi HA, Bilgic B, Harmanci H. The attitude of elderly lay people towards the symptoms of dementia. International Psychogeriatrics / Ipa. 18: 251-8. PMID 16466587 DOI: 10.1017/S1041610205002784 |
0.735 |
|
| 2006 |
Poewe W, Wolters E, Emre M, Onofrj M, Hsu C, Tekin S, Lane R. Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: an active treatment extension study. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 456-61. PMID 16229010 DOI: 10.1002/Mds.20700 |
0.424 |
|
| 2006 |
Emre M. Rivastigmine in Parkinson??s Disease Dementia Cns Drugs. 20: 748-750. DOI: 10.2165/00023210-200620090-00004 |
0.308 |
|
| 2006 |
Bronnick K, Emre M, De Deyn P, Tekin S, Aarsland D. II.P17 Different cognitive profiles in Alzheimer's disease and dementia associated with Parkinson's Disease Parkinsonism & Related Disorders. 12: 29. DOI: 10.1016/S1353-8020(07)70096-2 |
0.325 |
|
| 2006 |
Bilgiç B, Samancı B, Tufekcioglu Z, Tatlidede AD, Dursun E, Gezen-Ak D, Hanagasi HA, Gurvit HI, Emre M. P2-302: CLINICAL FEATURES AND DIAGNOSIS OF EARLY ONSET DEGENERATIVE DEMENTIAS IN TURKEY Alzheimer's & Dementia. 14: P798-P798. DOI: 10.1016/J.Jalz.2018.06.992 |
0.316 |
|
| 2006 |
Emre M. S1-04-02: Treatment of dementia associate to PD Alzheimer's & Dementia. 2: S6-S6. DOI: 10.1016/J.Jalz.2006.05.028 |
0.352 |
|
| 2006 |
Emre M. Rivastigmine in Parkinson's disease dementia: A viewpoint by Murat Emre Cns Drugs. 20: 748. |
0.308 |
|
| 2005 |
McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, Cummings J, Duda JE, Lippa C, Perry EK, Aarsland D, Arai H, Ballard CG, Boeve B, Burn DJ, et al. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology. 65: 1863-72. PMID 16237129 DOI: 10.1212/01.Wnl.0000187889.17253.B1 |
0.386 |
|
| 2005 |
Hanagasi HA, Emre M. Treatment of behavioural symptoms and dementia in Parkinson's disease. Fundamental & Clinical Pharmacology. 19: 133-46. PMID 15810893 DOI: 10.1111/J.1472-8206.2005.00317.X |
0.387 |
|
| 2005 |
Hanagasi HA, Ayribas D, Baysal K, Emre M. Mitochondrial complex I, II/III, and IV activities in familial and sporadic Parkinson's disease. The International Journal of Neuroscience. 115: 479-93. PMID 15809215 DOI: 10.1080/00207450590523017 |
0.341 |
|
| 2004 |
Geula C, Emre M, Friedland RP. The 2nd International Symposium on Alzheimer's disease and related disorders in the Middle East, May 1-3, 2003, Istanbul, Turkey. Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis. 11: 276-80. PMID 15678765 DOI: 10.1080/13506120400016232 |
0.344 |
|
| 2004 |
Emre M, Aarsland D, Albanese A, Byrne EJ, Deuschl G, De Deyn PP, Durif F, Kulisevsky J, van Laar T, Lees A, Poewe W, Robillard A, Rosa MM, Wolters E, Quarg P, et al. Rivastigmine for dementia associated with Parkinson's disease. The New England Journal of Medicine. 351: 2509-18. PMID 15590953 DOI: 10.1056/Nejmoa041470 |
0.45 |
|
| 2004 |
Emre M. Dementia in Parkinson's disease: cause and treatment. Current Opinion in Neurology. 17: 399-404. PMID 15247534 DOI: 10.1097/01.wco.0000137529.30750.ab |
0.363 |
|
| 2004 |
Boada-Rovira M, Brodaty H, Cras P, Baloyannis S, Emre M, Zhang R, Bahra R. Efficacy and safety of donepezil in patients with Alzheimer's disease: results of a global, multinational, clinical experience study. Drugs & Aging. 21: 43-53. PMID 14715043 DOI: 10.2165/00002512-200421010-00004 |
0.412 |
|
| 2004 |
Dursun E, Gezen-Ak D, Eker E, Ertan T, Engin F, Hanagasi H, Gurvit H, Emre M, Yilmazer S. P4-126 Presenilin-1 gene intronic polymorphism in late-onset Alzheimer's disease Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81684-1 |
0.362 |
|
| 2004 |
Ak DG, Dursun E, Ertan T, Bilgic B, Gurvit H, Emre M, Eker E, Engin F, Yilmazer S. P4-105 Interleukin 1α gene C(−889)T polymorphism in late-onset Alzheimer's disease Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81663-4 |
0.311 |
|
| 2004 |
Emre M, Onofrj M, Tekin S, Quarg P, Lane R. O1-05-03 Benefits of rivastigmine in Parkinson's disease dementia: results from the express study Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)80062-9 |
0.361 |
|
| 2003 |
Gauthier S, Emre M, Farlow MR, Bullock R, Grossberg GT, Potkin SG. Strategies for continued successful treatment of Alzheimer's disease: switching cholinesterase inhibitors. Current Medical Research and Opinion. 19: 707-14. PMID 14687441 DOI: 10.1185/030079903125002450 |
0.336 |
|
| 2003 |
Harmanci H, Emre M, Gurvit H, Bilgic B, Hanagasi H, Gurol E, Sahin H, Tinaz S. Risk factors for Alzheimer disease: a population-based case-control study in Istanbul, Turkey. Alzheimer Disease and Associated Disorders. 17: 139-45. PMID 14512826 DOI: 10.1097/00002093-200307000-00003 |
0.336 |
|
| 2003 |
Emre M. What causes mental dysfunction in Parkinson's disease? Movement Disorders : Official Journal of the Movement Disorder Society. 18: S63-71. PMID 14502658 DOI: 10.1002/Mds.10565 |
0.425 |
|
| 2003 |
Emre M, Lees AJ. Parkinsonism and dementia: Synucleinopathies, Tauopathies and Beyond Movement Disorders. 18: 1-1. PMID 14502649 DOI: 10.1002/Mds.10556 |
0.405 |
|
| 2003 |
Gershanik O, Emre M, Bernhard G, Sauer D. Efficacy and safety of levodopa with entacapone in Parkinson's disease patients suboptimally controlled with levodopa alone, in daily clinical practice: an international, multicentre, open-label study. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 27: 963-71. PMID 14499313 DOI: 10.1016/S0278-5846(03)00156-8 |
0.36 |
|
| 2003 |
Emre M. Dementia associated with Parkinson's disease. The Lancet. Neurology. 2: 229-37. PMID 12849211 DOI: 10.1016/S1474-4422(03)00351-X |
0.447 |
|
| 2003 |
Emre M, Farlow M, Bullock R, Gauthier S, Grossberg G, Potkin SG. Cholinesterase inhibitors in Alzheimer's disease: A consensus view on managing treatment failure Primary Care Psychiatry. 9: 29-30. DOI: 10.1185/135525703125002739 |
0.322 |
|
| 2002 |
Hanagasi HA, Gurvit IH, Ermutlu N, Kaptanoglu G, Karamursel S, Idrisoglu HA, Emre M, Demiralp T. Cognitive impairment in amyotrophic lateral sclerosis: evidence from neuropsychological investigation and event-related potentials. Brain Research. Cognitive Brain Research. 14: 234-44. PMID 12067696 DOI: 10.1016/S0926-6410(02)00110-6 |
0.738 |
|
| 2002 |
Sahin HA, Gurvit IH, Bilgiç B, Hanagasi HA, Emre M. Therapeutic effects of an acetylcholinesterase inhibitor (donepezil) on memory in Wernicke-Korsakoff's disease. Clinical Neuropharmacology. 25: 16-20. PMID 11852291 DOI: 10.1097/00002826-200201000-00003 |
0.74 |
|
| 2002 |
Hanagasi HA, Emre M. Management of the Neuropsychiatric and Cognitive Symptoms in Parkinson’s Disease Practical Neurology. 2: 94-102. DOI: 10.1046/J.1474-7766.2002.00404.X |
0.422 |
|
| 2001 |
Hanagasi HA, Gürol E, Sahin HA, Emre M. Atypical neurological involvement associated with celiac disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 8: 67-9. PMID 11509083 DOI: 10.1046/J.1468-1331.2001.00155.X |
0.304 |
|
| 2001 |
Barlas O, HanaÄŸasi HA, Imer M, Sahin HA, Sencer S, Emre M. Do unilateral ablative lesions of the subthalamic nucleu in parkinsonian patients lead to hemiballism? Movement Disorders : Official Journal of the Movement Disorder Society. 16: 306-10. PMID 11295786 DOI: 10.1002/Mds.1051 |
0.322 |
|
| 2000 |
McKeith I, Del Ser T, Spano P, Emre M, Wesnes K, Anand R, Cicin-Sain A, Ferrara R, Spiegel R. Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study. Lancet. 356: 2031-6. PMID 11145488 DOI: 10.1016/S0140-6736(00)03399-7 |
0.43 |
|
| Show low-probability matches. |